ABMS 5307. Translational Medicine and Drug Development. 3 Hours.
Students gain a comprehensive understanding of translational medicine and the process of transforming basic scientific discoveries into clinical applications, with a particular focus on drug development. They examine the stages of drug discovery, from target identification and preclinical testing to phase I–III clinical trials. Students address the scientific, regulatory, and ethical challenges involved in developing new therapies and study topics such as the role of biomarkers in clinical trials, the integration of personalized medicine in drug development, and the influence of regulatory agencies (e.g., FDA) on drug approval processes. They also consider patient advocacy, public health implications, and the use of artificial intelligence tools in translational medicine and drug development.
Prerequisite: ABMS 5301, ABMS 5302, ABMS 5303 & ABMS 5304.
